Financhill
Back

ANI Pharmaceuticals 10K Form

Sell
45

ANIP
ANI Pharmaceuticals

Last Price:
56.07
Seasonality Move:
6.92%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive ANIP News And Ratings

See the #1 stock for the next 7 days that we like better than ANIP

ANIP Financial Statistics

Sales & Book Value

Annual Sales: $486.82M
Cash Flow: $12.97M
Price / Cash Flow: 11.47
Annual Sales: $21.64
Price / Book: 2.58

Profitability

EPS (TTM): 1.15000
Net Income (TTM): $27.02M
Gross Margin: $305.3M
Return on Equity: 5.86%
Return on Assets: 3.01%

ANI Pharmaceuticals Earnings Forecast

Key ANI Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 16 years for ANIP is 62.71%.
  • The Selling, General & Administrative Expenses for ANIP have been equal to 33.22% of Gross Profit Margin.
  • The Research & Development expenses have been 7.04% of Revenue.
  • The Interest Expense is 143.46% of Operating Income.
  • The Net Earning history of ANIP is 3.86% of Total Revenues.
  • Per Share Earnings over the last 26 years have been positive in 12 years.

ANI Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: ANIP
CUSIP: 00182C
Website: anipharmaceuticals.com

Debt

Debt-to-Equity Ratio: 0.59
Current Ratio: 3.97
Quick Ratio: 2.95

Price-to-Earnings

Trailing P/E Ratio: 65.91
Forward P/E Ratio: 10.1

ANIP Technical Analysis vs Fundamental Analysis

Sell
45
ANI Pharmaceuticals (ANIP) is a Sell

Is ANI Pharmaceuticals a Buy or a Sell?